» Articles » PMID: 28097131

Genome-Wide Identification of Long Noncoding RNAs in Human Intervertebral Disc Degeneration by RNA Sequencing

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2017 Jan 19
PMID 28097131
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) are emerging as crucial players in a myriad of biological processes. However, the precise mechanism and functions of most lncRNAs are poorly characterized. In this study, we presented genome-wide identification of lncRNAs in the patients with intervertebral disc degeneration (IDD) and spinal cord injury (control) using RNA sequencing (RNA-seq). A total of 124.6 million raw reads were yielded using Hiseq 2500 platform and approximately 88% clean reads could be aligned to human reference genome in both IDD and control groups. RNA-seq profiling indicated that 1,854 lncRNAs were differentially expressed (log2 fold change ≥ 1 or ≤-1, < 0.05), in which 1,530 could potentially target 6,386 genes via -regulatory effects. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for these target genes suggested that lncRNAs were involved in diverse pathways, such as lysosome, focal adhesion, and MAPK signaling. In addition, a competing endogenous RNA (ceRNA) network was constructed for analyzing the function of lncRNAs. Further, quantitative real time PCR (qRT-PCR) was used to confirm the differentially expressed lncRNAs and ceRNA network. In conclusion, our results present the first global identification of lncRNAs in IDD and may provide candidate diagnostic biomarkers for IDD treatment.

Citing Articles

Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


Biomarkers for intervertebral disc and associated back pain: From diagnosis to disease prognosis and personalized treatment.

Leite Pereira C, Grad S, Goncalves R JOR Spine. 2023; 6(4):e1280.

PMID: 38156062 PMC: 10751979. DOI: 10.1002/jsp2.1280.


LINC00969 inhibits proliferation with metastasis of breast cancer by regulating phosphorylation of PI3K/AKT and ILP2 expression through HOXD8.

Wen X, Hou Y, Zhou L, Fang X PeerJ. 2023; 11:e16679.

PMID: 38130932 PMC: 10734406. DOI: 10.7717/peerj.16679.


Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis.

Yu J, Li C Immun Inflamm Dis. 2023; 11(4):e772.

PMID: 37102649 PMC: 10108685. DOI: 10.1002/iid3.772.


Targeting lncRNAs of colorectal cancers with natural products.

Sung W, Hong J Front Pharmacol. 2023; 13:1050032.

PMID: 36699052 PMC: 9868597. DOI: 10.3389/fphar.2022.1050032.


References
1.
Wang Z, Gerstein M, Snyder M . RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2008; 10(1):57-63. PMC: 2949280. DOI: 10.1038/nrg2484. View

2.
Gore M, Sadosky A, Stacey B, Tai K, Leslie D . The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976). 2011; 37(11):E668-77. DOI: 10.1097/BRS.0b013e318241e5de. View

3.
Alvarez-Dominguez J, Hu W, Yuan B, Shi J, Park S, Gromatzky A . Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2013; 123(4):570-81. PMC: 3901070. DOI: 10.1182/blood-2013-10-530683. View

4.
Sun Z, Wan Z, Liu Z, Guo Y, Yin J, Duan C . Expression of soluble Fas and soluble FasL in human nucleus pulposus cells. Int J Clin Exp Pathol. 2013; 6(8):1567-73. PMC: 3726972. View

5.
Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View